Fast Five Quiz: Idiopathic Pulmonary Fibrosis Imaging

Ani Kapoor, MD; Zab Mosenifar, MD

Disclosures

June 21, 2022

Idiopathic pulmonary fibrosis (IPF) is a rare form of chronic, progressive fibrosing interstitial pneumonia of unknown etiology. Global incidence and prevalence of IPF are between 0.09 and 1.30 per 10,000 people, according to Mei and colleagues. IPF is characterized by irreversible loss of lung function due to fibrosis, which leads to symptoms of increasing cough and dyspnea as well as impaired quality of life. Prognosis is poor, with a mean survival time of approximately 4 years without antifibrotic treatment. Newer drug treatments may slow progression of the disease, highlighting the importance of early diagnosis and treatment initiation.

How much do you know about imaging in IPF? Test your knowledge with this quick quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....